| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f7b665fb8f15d0e2b0911539d39f8a2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 |
| filingDate |
2005-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b90547366f57fef3d834ac36c0d336fe |
| publicationDate |
2007-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1743637-A1 |
| titleOfInvention |
Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome |
| abstract |
The present invention relates to the use of substituted pyrazole compounds for the treatment of metabolic syndrome in humans and animals and to corresponding medicaments. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102009036604-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8324268-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102008015033-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8399682-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013079586-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014174457-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8314089-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8546438-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011012630-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014027112-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102012016908-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102011055815-A1 |
| priorityDate |
2005-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |